NDAORALTABLET, EXTENDED RELEASE
Approved
Oct 1980
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
1
Data completeness
2/8 — Basic
Drug data last refreshed 17h ago · AI intelligence enriched 1mo ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
AFRINOL is an oral extended-release tablet containing pseudoephedrine sulfate, a decongestant used to relieve nasal and sinus congestion. It works by stimulating alpha-adrenergic receptors to reduce blood vessel swelling in the nasal passages. The product is indicated for symptomatic relief of upper respiratory congestion.
LOE Approaching
LOE approaching signals declining commercial opportunity; expect reduced headcount and consolidation of brand support functions.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (1)
Bioequivalence Study of Desloratadine and Pseudoephedrine Sulfate Extended-release Tablets Under Fasting Conditions
Started Apr 2006
34 enrolled
Healthy
Career Relevance
Zero linked job openings signal that AFRINOL is in a legacy maintenance phase with minimal hiring. Roles available are primarily in field sales and brand management focused on defending market share against generics rather than growth initiatives.
Brand Manager
Worked on AFRINOL at Merck & Co.? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.